This sophisticated system operates through a dual mechanism: the CAR component facilitates precise tumor cell targeting and internalization via receptor-mediated endocytosis, while simultaneously delivering therapeutic payloads-SN38 mediates direct antitumor activity and endogenous CXCL10 within CAR-M-Exosomes provides immunomodulatory functions. Here, CXCL10 is linked to neoplasm.